S9 Epidemiology & genetics :
Pharmacogenomics in type 2 diabetes
Friday 14 October 16:00~18:00 | Place: Emerald Hall B
Chairs: In-Kyu Lee, Taekeun Oh
    • Individual traits that affect response to specific drugs have a key role in personalized diabetes management. Rapid advances in knowledge of patient-specific pharmacology occur via the application of new molecular technology in gene-focused (pharmacogenetics) and genome-wide (pharmacogenomics) analyses. Professor Kyung-Sand Yu (Seoul National University, Korea) will provide the overview for pharmacogenomics and personized drug therapy. Subsequently, Professor Richard Watanebe (University of Southern California, USA), Professor Hye Seung Jung (Seoul National University, Korea), and Professor Su-Jun Lee (Inje University, Korea) will give us lectures on the personized medicine more specifically focusing on PPAR-gamma, sulfonylurea and anti-platelet agents, respectively.
Kyung-Sang Yu Seoul National University, Korea S9-1 Pharmacogenomics and personalized drug therapy
Richard M. Watanabe University of Southern California, USA S9-2 Human genomic analysis of type 2 diabetes and its translation to clinical care
Hye Seung Jung Seoul National University, Korea S9-3 Whole exome sequencing revealed variants associated with dependency on sulfonylureas in type 2 diabetes
Su-Jun Lee Inje University, Korea S9-4 Pharmacogenomics for the anti-platelet drug
Quick Menu
Registration
Abstract
On-line submission
Venue
venue
Top